AgomAb Therapeutics NV (AGMB)
7.90
-0.06
(-0.75%)
USD |
NASDAQ |
Oct 29, 10:39
AgomAb Therapeutics Total Liabilities (Quarterly) : 26.78M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 26.78M |
| Date | Value |
|---|---|
| December 31, 2024 | 18.93M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| Invion Ltd. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 180.52M |
| Shareholders Equity (Quarterly) | 153.74M |